Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports

BACKGROUND: Adverse drug reaction (ADR) is a major burden for patients and healthcare industry. Early and accurate detection of potential ADRs can help to improve drug safety and reduce financial costs. Post-market spontaneous reports of ADRs remain a cornerstone of pharmacovigilance and a series of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruoqi, Zhang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918608/
https://www.ncbi.nlm.nih.gov/pubmed/31849321
http://dx.doi.org/10.1186/s12911-019-0999-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918608/
https://www.ncbi.nlm.nih.gov/pubmed/31849321
http://dx.doi.org/10.1186/s12911-019-0999-1

Ejemplares similares